Article info
PDFTreatment
bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
- Correspondence to Professor Norbert Blank; norbert.blank{at}med.uni-heidelberg.de
Citation
bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
Publication history
- Received October 9, 2023
- Accepted April 6, 2024
- First published April 23, 2024.
Online issue publication
August 27, 2024
Article Versions
- Previous version (23 April 2024).
- Previous version (20 July 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.